{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T03:06:20Z","timestamp":1648782380672},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1993,11,1]],"date-time":"1993-11-01T00:00:00Z","timestamp":752112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[1993,11]]},"DOI":"10.1007\/bf01742255","type":"journal-article","created":{"date-parts":[[2005,6,13]],"date-time":"2005-06-13T20:04:49Z","timestamp":1118693089000},"page":"387-396","source":"Crossref","is-referenced-by-count":2,"title":["IgM monoclonal antibody JD118 recognizes an inducible antigen target for human-complement-mediated cytotoxicity against neoplastic B cells"],"prefix":"10.1007","volume":"36","author":[{"given":"Myron S.","family":"Czuczman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Garin-Chesa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto M.","family":"Lemoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Scheinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01742255_CR1","first-page":"1203","volume":"62","author":"ED Ball","year":"1983","unstructured":"Ball ED, Bernier GM, Cornwell GG III, McIntyre OR, O'Donnell JF, Fanger MW (1983) Monoclonal antibodies to myeloid differentiation antigens: in vivo studies of three patients with acute myelogenous leukemia. Blood 62: 1203","journal-title":"Blood"},{"key":"BF01742255_CR2","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1200\/JCO.1987.5.9.1430","volume":"5","author":"NK Cheung","year":"1987","unstructured":"Cheung NK, Lazarus H, Miraldi FD, Abramowsky CR, Kallick S, Saarinen UM, Spitzer T, Strandjord SE, Coccia PF, Berger NA (1987) Ganglioside GD2 specific monoclonal antibody 3F8: a phase 1 study in patients with neuroblastoma and malignant melanoma. J Clin Oncol 5: 1430","journal-title":"J Clin Oncol"},{"key":"BF01742255_CR3","first-page":"787","volume":"4","author":"MS Czuczman","year":"1991","unstructured":"Czuczman MS, Divgi CR, Straus DJ, Lovett DR, Garin-Chesa P, Yeh S, Feirt N, Graham M, Leibel S, Gee TS, Myers J, Pentlow K, Finn R, Schwartz M, Oettgen HF, Larson SM, Old LJ, Scheinberg DA (1991)131Iodine-labeled monoclonal antibody therapy of acute myelogenous leukemia and B cell lymphoma. Antibody Immunoconjugates Radiopharmaceut 4: 787","journal-title":"Antibody Immunoconjugates Radiopharmaceut"},{"key":"BF01742255_CR4","first-page":"17","volume":"1","author":"SJ Denardo","year":"1988","unstructured":"Denardo SJ, Denardo GL, O'Grady LF, Levy NB, Mills SL, Macey DJ, McGahan JP, Miller CH, Epstein AL (1988) Pilot studies of radioimmunotherapy of B cell lymphoma and leukemia using I-131 lym-1 monoclonal antibody. Antibody Immunoconjugates Radiopharmaceut 1: 17","journal-title":"Antibody Immunoconjugates Radiopharmaceut"},{"key":"BF01742255_CR5","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1182\/blood.V73.6.1431.1431","volume":"73","author":"MJS Dyer","year":"1989","unstructured":"Dyer MJS, Hale G, Hayhoe FGJ, Waldmann H (1989) Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype. Blood 73: 1431","journal-title":"Blood"},{"key":"BF01742255_CR6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/36.4.2831267","volume":"36","author":"P Garin-Chesa","year":"1988","unstructured":"Garin-Chesa P, Rettig WJ, Thomson PM, Old LJ, Melamed MR (1988) Immunohistochemical analysis of nerve growth factor receptor expression in normal and malignant human tissues. J Histochem Cytochem 36: 383","journal-title":"J Histochem Cytochem"},{"key":"BF01742255_CR7","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1200\/JCO.1991.9.4.548","volume":"9","author":"DM Goldenberg","year":"1991","unstructured":"Goldenberg DM, Horowitz JA, Sharkey RM, Hall TC, Murthy S, Goldenberg H, Lee RE, Stein R, Siegel JA, Izon DO, Burger K, Swayne LC, Belisle E, Hansen HJ, Pinsky CM (1991) Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody. J Clin Oncol 9: 548","journal-title":"J Clin Oncol"},{"key":"BF01742255_CR8","first-page":"670","volume-title":"Leucocyte typing IV: white cell differentiation antigens","author":"MR Hadam","year":"1989","unstructured":"Hadam MR (1989) Cluster report: CDw52. In: Knapp W, D\u00f6rken B, Gilks WR, Rieber EP, Schmidt RE, Stein H, Kr von dem Borne AEG (eds) Leucocyte typing IV: white cell differentiation antigens. Oxford University Press, New York, pp 670\u2013673"},{"key":"BF01742255_CR9","first-page":"321","volume":"1","author":"G Hale","year":"1983","unstructured":"Hale G, Swirsky DM, Hayhoe FGJ, Waldmann H (1983) Effects of monoclonal anti-lymphocyte antibodies in vivo in monkeys and humans. Mol Biol Med 1: 321","journal-title":"Mol Biol Med"},{"key":"BF01742255_CR10","first-page":"430","volume-title":"Antibodies: a laboratory manual","author":"E Harlow","year":"1990","unstructured":"Harlow E, Lane D (1990) Antibodies: a laboratory manual, 1st edn. Cold Spring Harbor Laboratory, New York, pp 430\u2013433, 471\u2013510","edition":"1st edn."},{"key":"BF01742255_CR11","first-page":"165","volume":"13","author":"AN Houghton","year":"1986","unstructured":"Houghton AN, Scheinberg DA (1986) Monoclonal antibodies: potential applications to the treatment of cancer. Semin Oncol 13: 165","journal-title":"Semin Oncol"},{"key":"BF01742255_CR12","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1073\/pnas.82.4.1242","volume":"82","author":"AN Houghton","year":"1985","unstructured":"Houghton AN, Mintzer D, Cordon-Cardo C, Welt S, Fliegel B, Vadhan S, Carswell E, Melamed MR, Oettgen HF, Old LJ (1985) Mouse monoclonal antibody detecting GD3 ganglioside: a phase 1 trial in patients with malignant melanoma. Proc Natl Acad Sci USA 82: 1242","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01742255_CR13","first-page":"2651","volume":"49","author":"J Kantor","year":"1989","unstructured":"Kantor J, Tran R, Greiner J, Pestka S, Fisher PB, Shivey JE, Schlom J (1989) Modulation of carcinoembryonic antigen messenger RNA levels in human colon carcinoma cells by recombinant human \u03b3-interferon. Cancer Res 49: 2651","journal-title":"Cancer Res"},{"key":"BF01742255_CR14","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1182\/blood.V72.4.1329.1329","volume":"72","author":"DC Kaufman","year":"1988","unstructured":"Kaufman DC, Baer MR, Gao XZ, Wang Z, Preisler HD (1988) Enhanced expression of the granulocyte-macrophage colony stimulating factor gene in acute myelocytic leukemia cells following in vitro blast cell enrichment. Blood 72: 1329","journal-title":"Blood"},{"key":"BF01742255_CR15","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/0161-5890(90)90081-A","volume":"27","author":"F Koichi","year":"1990","unstructured":"Koichi F, Welt S, Yin BWT, Feickert HJ, Takahashi T, Ueda R, Lloyd KO (1990) Analysis of the fine specificities of 11 mouse monoclonal antibodies reactive with type 2 blood group determinants. Mol Immunol 27: 723","journal-title":"Mol Immunol"},{"key":"BF01742255_CR16","first-page":"31","volume":"4","author":"JA Kuhn","year":"1991","unstructured":"Kuhn JA, Wong JYC, Beatty BG, Esteban JE, Williams L, Wanek P, Beatty JD (1991) Enhancement of sequential radioimmunotherapy with gamma interferon. Antibody Immunoconjugates Radiopharmaceut 4: 31(53a)","journal-title":"Antibody Immunoconjugates Radiopharmaceut"},{"key":"BF01742255_CR17","unstructured":"Nadler L, Beitmeyer J, Grossbard M, Spector N, Rabinowe S, Coral F, Ritz J, Schlossman S (1990) Anti-B4 blocked ricin immunotherapy for patients with B cell malignancies: phase 1 trial of 7 day continuous infusion. Blood 76: 364a"},{"key":"BF01742255_CR18","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1200\/JCO.1989.7.8.1027","volume":"7","author":"OW Press","year":"1989","unstructured":"Press OW, Eary JF, Badger CC, Martin PJ, Appelbaum FR, Levy R, Miller R, Brown S, Nelp WB, Krohn KA, Fisher D, Desantes K, Porter B, Kidd P, Thomas ED, Bernstein ID (1989) Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody. J Clin Oncol 7: 1027","journal-title":"J Clin Oncol"},{"key":"BF01742255_CR19","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1200\/JCO.1987.5.4.562","volume":"5","author":"ST Rosen","year":"1987","unstructured":"Rosen ST, Zimmer AM, Goldman-Leikin R, Gordon LI, Kazikiewicz JM, Kaplan EH, Variakojis D, Mander RJ, Dykewicz MS, Piergies A, Silverstein EA, Roenigk HH, Spies SM (1987) Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an131I-labeled monoclonal antibody: an Illinois cancer council study. J Clin Oncol 5: 562","journal-title":"J Clin Oncol"},{"key":"BF01742255_CR20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1148\/radiology.167.1.3347750","volume":"167","author":"KP Ryan","year":"1988","unstructured":"Ryan KP, Dillman RO, Denardo SJ, Denardo GL, Beauregard J, Hagan PL, Amox DG, Clutter ML, Burnett KG, Rulot CM, Sobol RE, Abramson I, Bartholomew RK, Frincke JM, Birdwell CR, Carlo DJ, O'Grady LF, Halpern SE (1988) Breast cancer imaging with In-111 human IgM monoclonal antibodies: preliminary studies. Radiology 167: 71","journal-title":"Radiology"},{"key":"BF01742255_CR21","first-page":"440","volume":"3","author":"DA Scheinberg","year":"1989","unstructured":"Scheinberg DA, Tanimoto M, McKenzie S, Strife A, Old LJ, Clarkson BD (1989) Monoclonal antibody M195: a diagnostic marker for acute myelogenous leukemia. Leukemia 3: 440","journal-title":"Leukemia"},{"key":"BF01742255_CR22","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ijc.2910350504","volume":"35","author":"RA Stahel","year":"1985","unstructured":"Stahel RA, Mabry M, Sabbath K, Speak JA, Bernal SD (1985) Selective cytotoxicity of murine monoclonal antibody LAM2 against human small-cell carcinoma in the presence of human complement: possible use for in vitro elimination of tumor cells from bone marrow. Int J Cancer 35: 587","journal-title":"Int J Cancer"},{"key":"BF01742255_CR23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1200\/JCO.1990.8.3.476","volume":"8","author":"RG Steis","year":"1990","unstructured":"Steis RG, Carrasquillo JA, McCabe R, Bookman MA, Reynolds JC, Larson SM, Smith JW II, Clark JW, Dailey V, Del Vecchio S, Shuke N, Pinsky CM, Urba WJ, Haspel M, Perentesis P, Paris B, Longo D, Hanna MG Jr (1990) Toxicity, immunogenicity, and tumor radioimmunodetecting ability of two human monoclonal antibodies in patients with metastatic colorectal carcinoma. J Clin Oncol 8: 476","journal-title":"J Clin Oncol"},{"key":"BF01742255_CR24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/ijc.2910370305","volume":"37","author":"K Sugita","year":"1986","unstructured":"Sugita K, Majdic O, Stockinger H, Holter W, K\u00f6ller U, Peschel C, Knapp W (1986) Use of a cocktail of monoclonal antibodies and human complement in selective killing of acute lymphocytic leukemia cells. Int J Cancer 37: 351","journal-title":"Int J Cancer"},{"key":"BF01742255_CR25","first-page":"339","volume":"3","author":"M Tanimoto","year":"1989","unstructured":"Tanimoto M, Scheinberg DA, Cordon-Cardo C, Huie D, Clarkson BD, Old LJ (1989) Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195. Leukemia 3: 339","journal-title":"Leukemia"},{"key":"BF01742255_CR26","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1182\/blood.V76.10.1908.bloodjournal76101908","volume":"76","author":"FM Uckun","year":"1990","unstructured":"Uckun FM (1990) Regulation of human B-cell ontogeny. Blood 76: 1908","journal-title":"Blood"}],"container-title":["Cancer Immunology Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01742255.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01742255\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01742255","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T18:17:12Z","timestamp":1586283432000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01742255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,11]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1993,11]]}},"alternative-id":["BF01742255"],"URL":"https:\/\/doi.org\/10.1007\/bf01742255","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,11]]}}}